| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |